Trevena Announces Positive Top-line Results from Two Phase 3 Pivotal Efficacy Studies of Intravenous Oliceridine in Moderate-to-Severe Acute Pain Feb 21, 2017 7:00am EST
Trevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute Pain Jan 04, 2017 7:00am EST
Trevena Reports Third Quarter 2016 Financial Results and Provides Corporate Update Nov 03, 2016 7:00am EDT
Trevena to Webcast Thought Leader Symposium on Acute Pain Management and Present at the 2016 Annual Meeting of the American Society of Anesthesiologists Oct 17, 2016 4:16pm EDT
Trevena Reports Second Quarter 2016 Financial Results and Provides Corporate Update Aug 04, 2016 7:00am EDT
Trevena, Inc. Announces First Patients Enrolled in the APOLLO-1 and APOLLO-2 Phase 3 Pivotal Efficacy Studies of Oliceridine in Acute Pain Jun 08, 2016 7:00am EDT
